Vascular aspects in Alzheimer's disease

被引:0
|
作者
Skoog, I [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Hosp, Sect Psychiatry, Inst Clin Neurosci,Dept Psychiatry, SE-41345 Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease is a primary degenerative dementia and is not considered to be of vascular origin. Furthermore, severe cerebrovascular diseases are generally exclusionary for the clinical diagnosis. During recent years both epidemiological and neuropathological studies have suggested an association between Alzheimer's disease and several vascular risk factors, such as hypertension, inheritance of the apolipoprotein E epsilon4 allele, coronary heart disease, diabetes mellitus, ischaemic white matter lesions and generalised atherosclerosis. These findings may reflect an overdiagnosis of Alzheimer's disease in individuals with silent cerebrovascular disease or that cerebrovascular disease may affects the clinical expression of Alzheimer's disease. Further possibilities include that Alzheimer's disease may increase the risk of vascular disease or that vascular disease may stimulate the Alzheimer's disease process. Similar mechanisms may also be involved in the pathogenesis of both disorders, such as disturbances in the renin-angiotensin system, apoptosis, and psychological stress.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [31] Clinical aspects of inflammation in Alzheimer's disease
    Rosenberg, PB
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2006, 17 (06) : 503 - 514
  • [32] Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease
    Dhoat, Sasha
    Ali, Khalid
    Bulpitt, Christopher J.
    Rajkumar, Chakravarthi
    AGE AND AGEING, 2008, 37 (06) : 653 - 659
  • [33] Neuropsychiatric aspects of Alzheimer's disease.
    Ballard C.
    Walker M.
    Current Psychiatry Reports, 1999, 1 (1) : 49 - 60
  • [34] Cholinergic Aspects of Aging and Alzheimer's Disease
    Mesulam, Marsel
    BIOLOGICAL PSYCHIATRY, 2012, 71 (09) : 760 - 761
  • [35] Aspects of β-amyloid as a biomarker for Alzheimer's disease
    Andreasson, Ulf
    Portelius, Erik
    Andersson, Malin E.
    Blennow, Kaj
    Zetterberg, Henrik
    BIOMARKERS IN MEDICINE, 2007, 1 (01) : 59 - 78
  • [36] Molecular aspects of neurodegeneration in Alzheimer's disease
    Russo, C
    Venezia, V
    Salis, S
    Dolcini, V
    Schettini, G
    FUNCTIONAL NEUROLOGY, 2002, 17 (02) : 65 - 70
  • [37] Psychopathological aspects of Alzheimer's disease.
    Hinterhuber, H
    NEUROPSYCHIATRIE, 1996, 10 (03) : 144 - 147
  • [38] Genetic aspects of Alzheimer's disease (Review)
    El Kadmiri, N.
    Hamzi, K.
    El Moutawakil, B.
    Slassi, I.
    Nadifi, S.
    PATHOLOGIE BIOLOGIE, 2013, 61 (06): : 228 - 238
  • [39] Clinical aspects of microbleeds in Alzheimer's disease
    van der Flier, Wiesje M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 322 (1-2) : 56 - 58
  • [40] Genetic and Genomic Aspects of Alzheimer's Disease
    Chua, Sze-Ming
    Ng, Beng-Yeong
    Lee, Tih-Shih
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (04) : 334 - 341